Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice

Biotechnology Advances

Volumn 30, Issue 1, 2012, Pages 310-320

  Akhtar, Feroz ^a,b   Rizvi, M Moshahid Alam ^b   Kar, Santosh Kumar ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Anti malarial activity; Bioavailability; Curcumin bound chitosan nanoparticles; Hemozoin synthesis inhibition

Indexed keywords

BIOAVAILABILITY; CHEMICAL INSTABILITY; CHITOSAN NANOPARTICLES; CURCUMIN; DOSE-DEPENDENT MANNER; HEMOZOIN; IN-VITRO; MOUSE PLASMA; ORAL DELIVERY; PARASITE-; ROOM TEMPERATURE;

BIOCHEMISTRY; CHEMICAL STABILITY; CHITOSAN; CONFOCAL MICROSCOPY; MAMMALS; MULTILAYERS; PORPHYRINS;

NANOPARTICLES;

ANTIMALARIAL AGENT; CHITOSAN; CURCUMIN; HEME; NANOPARTICLE;

ANTIMALARIAL AGENT; BIOAVAILABILITY; BLOOD; CHEMICAL BINDING; DOSE-RESPONSE RELATIONSHIP; MICROSCOPY; NANOTECHNOLOGY; PLASMA; POLYMERIZATION; PROTIST; RODENT; SURVIVAL;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG STABILITY; ERYTHROCYTE; FEMALE; IC 50; MALARIA; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; PLASMODIUM YOELII;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; BIOLOGICAL AVAILABILITY; CHITOSAN; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; ERYTHROCYTES; FEMALE; HEME; INHIBITORY CONCENTRATION 50; MALARIA; MICE; NANOPARTICLES; PLASMODIUM YOELII;

MUS; PLASMODIUM YOELII;

EID: 84855746005     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.05.009     Document Type: Article

References (44)

1. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009, 30:85-94.
2. Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007, 595:1-75.
3. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4:807-818.
4. Anitha A., Deepagan V.G., Divya Rani V.V., Menon D., Nair S.V., Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr Polymers 2011, 10.1016/j.carbpol.2011.01. 005.
5. Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994, 11:1358-1361.
6. Baudner B.C., Balland O., Giuliani M.M., Von Hoegen P., Rappuoli R., Betbeder D., et al. Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles. Infect Immun 2002, 70:4785-4790.
7. Bentzen Peter J., Lang E., Lang F. Curcumin induced suicidal erythrocyte death. Cell Physiol Biochem 2007, 19:153-164.
8. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol 2007, 5:3.
9. Borchard G., Luessen H.L., De Boer A.G., Verhoef J.C., Lehr C.M., Junginger H.E. The potential of mucoadhesive polymers in enhancing intestinal peptide drus absorption. III: effect of chitosan glutamate and carbomer on epithelial tight junctionsin vitro. J Control Release 1996, 39:131-138.
10. Calvo P., Remuña'n-L'opez C., Vila-Jato J.L., Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997, 63:125-132.
11. Chou A.C., Fitch C.D. Heme polymerase: modulation by chloroquine treatment of a rodent malaria. Life Sci 1992, 51:2073-2078.
12. Dodane V., Khan M.A., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999, 182:21-32.
13. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
14. Hu Y., Ding Y., Ding D., Sun M., Zhang L., Jiang X., et al. Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. Biomacromolecules 2007, 8:1069-1076.
15. Jaganathan K.S., Rao Y.U., Singh P., Prabakaran D., Gupta S., Jain A., et al. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm 2005, 294:23-32.
16. Kamble Vishvajit A., Jagdale Deepali M., Kadam Vilasrao J. Nanosuspension a novel drug delivery system. Int J Pharm Bio Sci 2010, 1(4):352-360.
17. Kunwar A., Barik A., Pandey R., Priyadarsini K.I. Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta 2006, 1760:1513-1520.
18. Lao C.D., Ruffin M.T., Normolle D., Health D.D., Murray S.I., Bailey J.M., et al. Dose escalation of curcuminoid formulation. BMC Complement Altern Med 2006, 6:10-15.
19. Lee H.L. Enzymatic barriers to peptide and protein absorption. CRC Crit Rev Ther Drug Carrier Syst 1998, 5:69-97.
20. Leung M.H.M., Kee T.W. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir 2009, 25:5773-5777.
21. Ma Z., Yeoh H.H., Lim L.Y. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci 2002, 91(6):1396-1404.
22. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78(18):2081-2087.
23. May L.A., Tourkina E., Hoffman S.R. Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry. Anal Biochem 2005, 337:62-69.
24. Orjih A.U., Fitch C.D. Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine. Biochim Biophys Acta 1993, 1157:270-274.
25. Pan M.-H., Huang T.-M., Lin J.-K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999, 27:486-494.
26. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16:1217-1226.
27. Priyadarsini K.I. Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C: Photochem Rev 2009, 10:81-95.
28. Reddy R.C., Vatsala P.G., Keshamouni V.G., Padmanaban G., Rangarajan P.N. Curcumin for malaria therapy. BBRC 2005, 326(2):472-474.
29. Salmaso S., Bersani S., Semenzato A., Caliceti P. New cyclodextrin bioconugates for active tumor targeting. J Drug Target 2007, 15:379-390.
30. Shankar T., Shantha N., Ramesh H., Murthy I., Murthy V. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 1980, 18:73-75.
31. Sharma R.A., Steward W.P., Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 2007, 595:453-470.
32. Sirawaraporn W. Dihydrofolate reductase and antifolate resistance in malaria. Drug Resist Updat 1998, 1:397-406.
33. Sneharani A.H., Singh S.A., Appu Rao A.G. Interaction of alphaS1-casein with curcumin and its biological implications. J Agric Food Chem 2009, 57(21):10386-10389.
34. Sou K., Inenaga S., Takeoka S., Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int J Pharm 2008, 352:287-293.
35. Tiyaboonchai W., Tungpradit W., Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007, 337:299-306.
36. Trang D.T., Huy N.T., Uyen D.T., Sasai M., Shiono T., Harada S., et al. Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs. Anal Biochem 2006, 349:292-296.
37. Van der Lubben I.M., Kersten G., Fretz M.M., Beuvery C., Coos V.J., Junginger H.E. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 2003, 21:1400-1408.
38. Vemula P.K., Li J., John G. Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs. J Am Chem Soc 2006, 128:8932-8938.
39. Vila A., Sanchez A., Janes K., Behrens I., Kissel T., Vila J.J.L., et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004, 57:123-131.
40. Vinagradov S.V., Bronich T.K., Kabanov A.V. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Del Rev 2002, 54:223-233.
41. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., et al. Stability of curcumin in buffer solutions and characterization of its degradation products. Pharm Biomed Anal 1997, 15:1867-1876.
42. Winstanley P.A. Chemotherapy for Falciparum malaria: the armoury, the problems and the prospects. Parasitol Today 2000, 16(4):146-153.
43. World Malaria Report 2010.
44. Yuying Z., Yan Y., Kai T., Xing H., Guolin G. Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 2008, 107(2):891-897.